ASCE IRLV Intimate Care For Women

ASCE IRLV Intimate Care For Women Intimate Rejuvenation Exosome (Women’s Health) · Rosa damascena plant exosomes (ExoSCRT™) HA retinol vitamin C activator Quick Answer ASCE IRLV Intimate Care for Women by ExoCoBio is a Korean plant-derived exosome kit specifically formulated for intimate area rejuvenation — 20 mg lyophilized Rosa damascena callus exosomes (via ExoSCRT™ technology) plus a 2.5 mL activator containing hyaluronic acid, retinol, and vitamin C. The plant-origin vegan exosome platform delivers signalling cargo to vulvar and intimate skin for hydration, elasticity, and tissue regeneration. Course is typically 3–5 sessions every 2–4 weeks. Why This Product Is Different ASCE IRLV is one of the few exosome products specifically formulated for intimate care, distinct from ExoCoBio’s facial line (ASCE SRLV, ASCE HRLV, etc.). The plant-derived Rosa damascena callus exosome platform offers a vegan, non-animal alternative to mammalian-cell exosomes — important for some patient demographics. The activator contains hyaluronic acid for immediate hydration, retinol for cellular turnover, and vitamin C for antioxidant and brightening effect — a multi-active complement to the exosome signalling cargo. ExoCoBio’s ExoSCRT™ technology is the platform behind this product family. Mechanism of Action Plant Exosome Signalling for Intimate Tissue Regeneration. Rosa damascena callus-derived exosomes (30–150 nm extracellular vesicles) carry plant microRNAs, peptides, growth factors, and signalling lipids. Once delivered to intimate skin via topical, mesotherapy, or post-procedure application, the exosomes are taken up by local fibroblasts and epithelial cells, releasing their cargo into the cytoplasm. Downstream effects include fibroblast proliferation, collagen synthesis, anti-inflammatory cytokine modulation, and enhanced barrier function — all relevant for intimate skin atrophy and dryness. Specifications Product Name ASCE IRLV Intimate Care For Women Category Intimate Rejuvenation Exosome (Women’s Health) Active Ingredients 20 mg lyophilized exosomes derived from Rosa damascena callus (plant stem cell extracellular vesicles via ExoSCRT™ technology) 2.5 mL activator solution containing hyaluronic acid, retinol, and ascorbic acid (vitamin C). Plant-origin exosomes carrying signalling cargo for tissue regeneration, hydration, and anti-inflammatory modulation. Manufacturer ExoCoBio Inc. Origin Republic of Korea Pack 1 lyophilized exosome vial (20 mg dry powder) 1 activator vial (2.5 mL liquid). Two-vial kit format. Reconstitute by transferring activator into powder vial before use. Injection / Application Technique Topical application post-microneedling, mesotherapy with 30G–32G fine needle, or post-RF / post-laser delivery into intimate skin Depth / Application Method Superficial dermis of vulvar and intimate skin. Depth and technique per practitioner protocol — refer to manufacturer training. Treatment Protocol Course of 3–5 sessions, spaced 2–4 weeks apart. Maintenance every 3–6 months. Effect Duration 1–3 months per session; cumulative effect with repeat sessions Storage Store at 2–25 °C in a cool, dry place away from direct sunlight. Use immediately after reconstitution. Shelf Life 24 months from manufacturing date (unopened, lyophilized state) Regulatory Manufactured in the Republic of Korea by ExoCoBio Inc. The ASCE platform is positioned as a cosmeceutical / aesthetic product, not a medical device. ASCE IRLV is not FDA-approved. Use is restricted to licensed healthcare professionals operating within their jurisdiction’s regulatory framework. Not for self-administration. SKU FF-IH-ASCE-IRLV Clinical Indications Vulvar dryness and decreased natural lubrication Intimate skin elasticity loss (postpartum, postmenopausal) Mild intimate atrophy associated with hormonal changes Post-procedure recovery (post-laser intimate rejuvenation, post-RF) Intimate skin texture and tone improvement Adjunct to hormonal or laser intimate rejuvenation protocols Compare Within Category ASCE IRLV is currently the only product in Fillersfairy’s Intimate Rejuvenation Exosome subcategory. Within ExoCoBio’s broader ASCE portfolio: SRLV (facial), HRLV (hair / scalp), and IRLV (intimate) share the same ExoSCRT™ platform but with different activator compositions tuned for each anatomical site. Compare with traditional intimate rejuvenation approaches: laser-only (CO2 fractional, Er:YAG) or radiofrequency-only protocols, where ASCE IRLV serves as a regenerative adjunct. Frequently Asked Questions What is ASCE IRLV Intimate Care for Women? ASCE IRLV is a Korean plant-derived exosome kit from ExoCoBio specifically formulated for intimate area rejuvenation. It contains 20 mg lyophilized exosomes from Rosa damascena (rose) callus stem cells, plus a 2.5 mL activator with hyaluronic acid, retinol, and vitamin C. The IRLV variant (Intimate Rejuvenation Line — Vulvar) shares the ExoSCRT™ exosome platform with ExoCoBio’s facial and hair products but is formulated for intimate skin. Are the exosomes plant-derived or stem cell-derived? Plant-derived. Rosa damascena (rose) callus tissue is cultured, and extracellular vesicles (exosomes) are extracted from the callus cell culture via ExoCoBio’s ExoSCRT™ technology. This is a vegan, non-animal exosome source — distinct from mammalian cell line exosomes (mesenchymal stem cell, fibroblast, etc.). The plant-origin platform is important for patient demographics requiring vegan products or those concerned about animal-cell sources. How is ASCE IRLV different from ASCE Plus SRLV (facial)? Both share the ExoSCRT™ Rosa damascena callus exosome platform, but the activator and indication differ. SRLV (facial) activator is formulated for facial skin — different growth factor and active ingredient ratios. IRLV activator includes retinol and vitamin C alongside HA for intimate skin physiology. The 20 mg lyophilized exosome content is comparable; the application protocol differs significantly. Is ASCE IRLV FDA-approved for vaginal use? No. ASCE IRLV is not FDA-approved for any medical vaginal or intimate indication. It is positioned as a cosmeceutical / aesthetic product within ExoCoBio’s intimate care line. Use is restricted to licensed healthcare professionals operating within their jurisdiction’s regulatory framework. Practitioners should consult local regulations before clinical use for intimate indications. How is ASCE IRLV reconstituted and applied? Open the lyophilized exosome vial (20 mg dry powder) and the activator vial (2.5 mL liquid). Transfer the activator into the exosome vial. Gently agitate (do not shake) until fully dissolved. Apply via one of: (1) topical post-procedure (post-laser intimate rejuvenation, post-RF, post-microneedling) within 30 minutes, (2) superficial mesotherapy with 30G–32G needle, or (3) practitioner-specific protocols. Use immediately after reconstitution. How many sessions are recommended? Typical course is 3–5 sessions spaced 2–4 weeks apart. The exact protocol depends on indication and practitioner preference. Maintenance is one session every 3–6 months based on individual response. ASCE IRLV is often used as an adjunct to laser or radiofrequency intimate rejuvenation protocols rather than as standalone therapy. What indications does ASCE IRLV address? Primarily intimate skin atrophy and dryness associated with hormonal changes (postmenopausal, postpartum, lactational), mild elasticity loss, and post-procedure recovery for intimate rejuvenation interventions. Not indicated for clinically diagnosed vaginal atrophy requiring hormonal therapy, infection, malignancy, or any condition requiring medical management — these require medical evaluation. Are there contraindications? Absolute: active intimate infection (bacterial, fungal, viral), pregnancy, lactation, known hypersensitivity to any kit component (rose extract, retinol, ascorbic acid). Relative: active intimate dermatitis, recent intimate surgery (within 4–6 weeks), bleeding disorders, anticoagulant therapy without medical clearance, immunosuppression. Patients should be evaluated by a qualified practitioner before use. Where is ASCE IRLV manufactured? Manufactured by ExoCoBio Inc., a Korean biotechnology company specialising in exosome-based regenerative aesthetics. ExoCoBio’s ExoSCRT™ technology is the platform behind the ASCE product family (SRLV facial / HRLV hair / IRLV intimate). The company is headquartered in Korea and operates internationally. How much does ASCE IRLV cost? ASCE IRLV Intimate Care for Women is priced at USD $118.00 per kit on Fillersfairy, with wholesale pricing for licensed practitioners. Each kit is one reconstituted session. Source verification:→ Korean MFDS (regulatory authority) Related Skin Boosters ASCE Plus SRLV Exosome Facial Exosome ExoCoBio · Rosa damascena (facial variant) ASCE Plus SRLV Exosome Hanheal Exosome Facial Rejuvenation Facial Exosome BNC Global · fibroblast-derived Hanheal Exosome Facial Rejuvenation Exo One Exosome Facial Exosome Exosomes 6B HA activator Exo One Exosome 2XSOME Dual-Exosome Facial Exosome Stem-cell collagen activator 2XSOME Dual-Exosome → Browse all Skin Booster products Regulatory Notice. Manufactured in the Republic of Korea by ExoCoBio Inc. The ASCE platform is positioned as a cosmeceutical / aesthetic product, not a medical device. ASCE IRLV is not FDA-approved. Use is restricted to licensed healthcare professionals operating within their jurisdiction’s regulatory framework. Not for self-administration. This product is manufactured outside the United States. For licensed healthcare professionals only. Practitioners are responsible for verifying regulatory status of this product in their jurisdiction before clinical use. Not for retail sale. Pricing subject to change. Last reviewed May 30, 2026.